Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Clarifying the Optimal Application of SLT Therapy Trial

for
Glaucoma and Ocular Hypertension
Location: Nashville TN, Peoria IL, Orland Park IL, Chicago IL,
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT04967989

Phase 3, Recruiting
Active & Responsive

The Ailliance Post-Market Clinical Study

for
Spinal Deformity, Spinal Degenerative Disorder,
Location: Nashville TN, Louisville KY, Bloomington IN,
Sponsor: Medtronic Spinal and Biologics

Sex: All

Age: 18+

Code: NCT05856370

Recruiting
Active & Responsive

OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study

for
Lumbar Spine Disease, Lumbar Spondylolisthesis,
Location: Nashville TN, Paducah KY, Morgantown WV, Richmond VA,
Sponsor: Bioventus LLC

Sex: All

Age: 21 - 70+

Code: NCT05405374

Recruiting
Active & Responsive

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Nashville TN, Asheville NC, Ann Arbor MI, Fairfax VA,
Sponsor: Zenith Epigenetics

Sex: Male

Age: 18+

Code: NCT04986423

Phase 2, Recruiting
Active & Responsive

Global Paradise System US Post Approval Study

for
Hypertension, Cardiovascular Diseases, Vascular Diseases
Location: Nashville TN, Marietta GA, Spartanburg SC,
Sponsor: ReCor Medical, Inc.

Sex: All

Age: 18+

Code: NCT06297291

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

for
Depression
Location: Nashville TN, Atlanta GA, Bellaire TX, Milford CT,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06713616

Phase 3, Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

for
Asthma
Location: Hendersonville TN, East Point GA, St Louis MO,
Sponsor: Pfizer

Sex: All

Age: 18 - 70+

Code: NCT06977581

Phase 2, Recruiting

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

for
Alzheimer Disease, Dementia, Sleep Disorder, Sleep Disturbance
Location: Murfreesboro TN, San Marcos TX, Lakewood CO
Sponsor: University of Alabama, Tuscaloosa

Sex: All

Age: 50+

Code: NCT05820919

Recruiting

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

for
Prurigo Nodularis (PN)
Location: Murfreesboro TN, Birmingham AL, Indianapolis IN,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07236099

Phase 2, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Hermitage TN, Atlanta GA, Tuscaloosa AL, Germantown TN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Murfreesboro TN, Bowling Green KY, Evansville IN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: Murfreesboro TN, Birmingham AL, Macon GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Murfreesboro TN, Shelbyville TN, Lebanon TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Murfreesboro TN, Smyrna TN, Shelbyville TN, Lebanon TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase 1, Phase 2, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Murfreesboro TN, Smyrna TN, Shelbyville TN, Lebanon TN,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Murfreesboro TN, Smyrna TN, Shelbyville TN, Lebanon TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Murfreesboro TN, Smyrna TN, Shelbyville TN, Lebanon TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase 1, Phase 2, Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

for
Systemic Lupus Erythematosus (SLE)
Location: Murfreesboro TN, Charlotte NC, Willowbrook IL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 16+

Code: NCT07175285

Recruiting

Patient Retrospective Outcomes (PRO)

for
Chronic Pain
Location: Murfreesboro TN, Greenville SC, Cincinnati OH,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT01550575

Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Murfreesboro TN, Jackson TN, Marietta GA, Louisville KY,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase 3, Recruiting